Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007 Oct;13(7):382-5.
doi: 10.1016/j.parkreldis.2007.01.008. Epub 2007 Apr 2.

Identification of potential protein interactors of Lrrk2

Affiliations

Identification of potential protein interactors of Lrrk2

Justus C Dächsel et al. Parkinsonism Relat Disord. 2007 Oct.

Abstract

Pathogenic substitutions in the Lrrk2 protein have been shown to be an important cause of both familial and sporadic parkinsonism. The molecular pathway involved in Lrrk2 dopaminergic neuron degeneration remains elusive. Employing a combination of Lrrk2-mediated protein precipitation and tandem mass spectrometry, we identified 14 potential Lrrk2 binding partners. The majority of these interactions may be subgrouped into three functional cellular pathways: (i) chaperone-mediated response, (ii) proteins associated with the cytoskeleton and trafficking and (iii) phosphorylation and kinase activity. Future investigation of these candidates is now warranted and may help resolve the pathomechanism behind Lrrk2 neurodegeneration.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Representative silver stained gel showing examples of the identified proteins. Lysates of Lrrk2-V5 (1, 3) or MOCK (2) transfected HEK293T cells were subjected to immunoprecipitation using V5- (1,2) or myc-antibodies (3) and separated by SDS-PAGE electrophoresis.

Similar articles

Cited by

References

    1. Farrer MJ. Genetics of Parkinson disease: paradigm shifts and future prospects. Nat Rev Genet. 2006;7:306–318. - PubMed
    1. Marin I. The Parkinson Disease Gene LRRK2: Evolutionary and Structural Insights. Mol Biol Evol. 2006;23:2423–2433. - PubMed
    1. Mata IF, Wedemeyer WJ, Farrer MJ, Taylor JP, Gallo KA. LRRK2 in Parkinson's disease: protein domains and functional insights. Trends Neurosci. 2006;29:286–293. - PubMed
    1. Gloeckner CJ, Kinkl N, Schumacher A, Braun RJ, O'Neill E, Meitinger T, et al. The Parkinson disease causing LRRK2 mutation I2020T is associated with increased kinase activity. Hum Mol Genet. 2006;15:223–232. - PubMed
    1. Greggio E, Jain S, Kingsbury A, Bandopadhyay R, Lewis P, Kaganovich A, et al. Kinase activity is required for the toxic effects of mutant LRRK2/dardarin. Neurobiol Dis. 2006;23:329–341. - PubMed

Publication types

MeSH terms

Substances